Predictive assays of response to radiotherapy: Where do we stand in 1997?;Les tests predictifs de la reponse a la radiotherapie: Bilan et perspectives en 1997

Cancer/Radiotherapie

Volumn 1, Issue 5, 1997, Pages 473-483

  Dubray, B ^a,b   Pavy, J J ^a   Giraud, P ^a   Danhier, S ^a   Cosset, J M ^a  

^a INSTITUT CURIE   (France)

^b UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

Apoptosis; Intrinsic radiosensitivity; Normal tissues; Oxygen; Predictive assays; Proliferation; Radiotherapy

Indexed keywords

ANIMAL CELL; APOPTOSIS; CELL PROLIFERATION; CONFERENCE PAPER; NONHUMAN; OXYGENATION; PREDICTION; PRIORITY JOURNAL; RADIATION RESPONSE; RADIOSENSITIVITY; TREATMENT OUTCOME; TUMOR CELL; CELL CULTURE; CELL DIVISION; FLOW CYTOMETRY; HUMAN; NEOPLASM; PREDICTION AND FORECASTING; RADIATION EXPOSURE; RADIOTHERAPY; REVIEW;

APOPTOSIS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FLOW CYTOMETRY; HUMANS; NEOPLASMS; PREDICTIVE VALUE OF TESTS; RADIOTHERAPY; TUMOR CELLS, CULTURED;

EID: 0031463734     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(97)89591-1     Document Type: Conference Paper

References (80)

1. Antognoni P, Bignardi M, Cazzaniga LF, Poli AM, Richetti A, Bossi A et al. Accelerated radiation therapy for locally advanced squamous cell carcinomas of the oral cavity and oropharynx selected according to tumor cell kinetics: a phase D multicenter study. Ira J Radiat Oncol Biol Phys 1996;36:1137-45
2. Begg AC. The clinical status of Tpot as a predictor? Or why no tempest in the Tpot. Int J Radiat Oncol Biol Phys 1995;32: 1539-41
3. Bentzen SM. Potential clinical impact of normal-tissue intrinsic radiosensitivity testing. Radiother Oncol 1997;43:121-31
4. Bentzen SM, Overgaard J. Patient-to-patient variability in the expression of radiation-induced normal tissue injury. Semin Radiat Oncol 1994;4:68-80
5. Boiger BS, Symonds RP, Stanton PD, MacLean AB, Bumett R, Kelly P et al. Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rate. Br J Cancer 1996;74:1223-6
6. Bourhis J, Dendale R, Hill C, Bosq J, Janot F, Attal P et al. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 Gy in 7 weeks. Int J Radiat Oncol Biol Phys 1996;35:471-6
7. Britten RA, Evans AJ, Allalunis-Turner MJ, Franko AJ, Pearcey RG. Intratumoral heterogeneity as a confounding factor in clonogenic assays for tumour radioresponsiveness. Rod/other Onco/1996;39:145-53
8. Brock WA, Baker F, Wike JL, Sivon SL, Peters LJ. Cellular radiosensitivity of primary head and neck squamous cell carcinorras and local tumor control. Int J Radiat Oncol Biol Phys 1990; 18:1283-6
9. Brock WA, Tucker SL, Geara FB, Turesson I, Wike J, Nyman J et al. Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer. Int J Radiat Oncol Biol Phys 1995;32:1371-9
10. Brown JM, Giaccia AJ. Tumour hypoxia: the picture has changed in the 1990s. Int J Radiat Biol 1994;65:95-l 02
11. Brown MJ, Sun B. Hypoxia-specific cytotoxins in cancer therapy. Semin Radiat Oncol 1996;6:22-36
12. Burnet NO, Nyman J, Turesson I, Wurm R, Yarnold JR, Peacock JH. Prediction of normal-tissue tolerance to radiotherapy from in vitro cellular radiation sensitivity. Lancet 1992;339: 1.170-1
13. Buronfosse A, Thomas CP, Ginestet C, Dore JF. Radiosensitivity in vitro of clonogenic and non-clonogenic glioblastoma cells obtained from a human brain tumour. CR Acad Sei (série IU, Sciences de la Vie) 1994;317:1031-41
14. Chyle V, Pollack A, Czerniak B, Stephens CL, Zagars GK, Terry NHA et al. Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys 1996:35:281-7
15. Clark GM. Prognostic and predictive factors. In: Harris JR, Lippman ME, Morrow M, Hellman S, eds. Diseases of the Breast. Philadelphia:Lippincott - Raven, 1996:461-85
16. Cooke LD, Cooke TG, Forster G, Jones AS, Stell PM. Prospective evaluation of cell kinetics in head and neck squamous carcinoma: the relationship to tumour factors and survival. Br J Cancer 1994;69:717-20
17. Corvo R, Giaretti W, Geido E, Sanguineti G, Orecchia R, Scala M et al. Cell kinetics and tumor regression during radiotherapy in head and neck squamous cell carcinomas. Int J Cancer 1996;68:151-5
18. Cosset JM. Apoptose et radiothérapie. Bull Cancer/Radiother 1996;83:222-9
19. Cosset JM, Peters LJ, Girinsky T, Guichard M, Eschwège F, Mornex F et al. Les tests prédictifs de radiocurabilité : vers, une radiothérapie sur mesure? Bull Cancer/Radiother 1990;77: 83-94
20. Delanian S. Aspects physiopathologiques de la fibrose radioinduite. Bull Cancer/Radiother 1995;82:88-93
21. Denekamp J. Tumor stem cells: facts, interpretation and consequences. Radiother Oncol 1994;30:6-10
22. Dewey WC, Ling CC, Meyn RE. Radiation-induced apoptosis: relevance to radiotherapy. Int J Radiat Oncol Biol Phys 1995; 33:781-96
23. Dische S, Saunders MI, Barren A, Harvey A, Gibson D, Parmar MKB. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 1997;44:123-36
24. Dubray B, Breton C, Delic J, Klijanienko J, Maciorowski Z, Vielh P et al. In vitro radiation-induced apoptosis and early response to low-dose radiotherapy in non-Hodgkin's lymphoma. Radiother Oncol (à paraître)
25. Dubray B, Cosset JM. Évaluation du risque cancérigène aux faibles doses d'exposition aux radiations ionisantes. Arch Mal Prof (à paraître)
26. Dubray B, Maciorowsky Z, Cosset JM, Terry NHA. Intérêt clinique du temps de doublement potentiel (Tpot) mesuré par cytométrie de flux. Bull Cancer 1995;82:331-8
27. Dubray B, Mosseri V, Brunin F, Jaulerry C, Poncet P, Rodriguez J et al. Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study. Radiology 1996;201:553-8
28. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991 ;21:109-22
29. Falk SJ, Ward R, Blechen NM. The influence of carbogen breathing on tumour tissue oxygenation in man evaluated by computerised p02 histography. Br J Cancer 1992:66:919-24
30. Fyles A, Milosevic M, Kavanagh MC, Pintilie M, Sun A, Levin W et al. Hypoxia measured with a polarographic electrode correlates with radiation response in cervix cancer. Radiother Oncol (à paraître)
31. Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Moldofsky PJ, Hartz WH et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1988; 14:831-8
32. Geara FB, Peters LJ, Ang KK, Garden AS, Tucker SL, Levy LB et al. Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy. Int J Radiat Oncol Biol Phys 1996;35: 455-62
33. Giaccia AJ. Hypoxie stress proteins: survival of the fittest. Semin Radiat Oncol 1996;6:46-58
34. Girinsky T, Bernheim A, Lubin R, Tavakoli-Razavi T, Baker F, Janot F et al. In vitro parameters and treatment outcome in head and neck cancers treated with surgery and/or radiation: cell characterization and correlations with local control and overall survival. Int J Radiat Oncol Biol Phys 1994;30:789-94
35. Guichard M, Lartigau E. L'effet oxygène : bilan des connaissances et applications pratiques. Bull Cancer/Radiother 1991;78:441-53
36. Haustermans K, Hofland I, Pottie G, Ramaekers M, Begg AC. Can measurements of potential doubling time (Tpot) be compared between laboratories? A quality control study. Cytometry 1995:19:154-63
37. Hendry JH, West CML, Moore JV, Potten CS. Tumour stem cells: the relevance of predictive assays for tumour control after radiotherapy. Radiother Oncol 1994;30:11-6
38. Höckel M, Schienger K, Mitze M, Schaffer U, Vaupel P. Hypoxia and radiation response in human tumors. Semin Radiat Oncol 1996:6:3-9
39. Horiot JC, Bontemps P, Van den Bogaert W, Le Fur R, Van den Weingaert D, Bolla M et al. Accelerated fractionation compared to conventional fractionation improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22581 randomized trial. Radiother Oncnl 1997;44:111-21
40. Jaulerry C, Dubray B, Brunin F, Rodriguez J, Point D, Blaszka B et al. Prognostic value of tumor regression during radiotherapy for head and neck cancer: a prospective study. Int J Radiat Oncol Biol Phys 1995;33:271-9
41. Johansen J, Bentzen SM, Overgaard J, Overgaard M. Evidence for a positive correlation between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy. Int J Radiat Biol 1994;66: 407-12
42. Johnson CR, Thames HD, Huang DT, Schmidt-Ullrich RK. The tumor volume and clonogen number relationship: tumor control predictions based on tumor volume estimates derived from corn-puted tomography. Int J Radiat Oncol Biol Phys 1995; 33:281-7
43. Kolstad P. Vascularization, Oxygen Tension and Radiocurability. Copenhagen: Scandinavian University Books, 1963
44. Lambin P, Malaise EP, Joiner MC. Might intrinsic radioresistance of human tumour cells be induced by radiation? Int J Radial Biol 1996;69:279-90
45. Leoncini L, Del Vecchio MT, Megha T, Barbini P, Galieni P, Pileri S et al. Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am J Pathol 1993; 142:755-63
46. Leprat F, Alapetite C, Rosselli F, Ridet A, Schlumberger M, Sarasin A et al. Impaired DNA repair as assessed by the "comet" assay in patients developing thyroid carcinoma after radiotherapy [Abstract]. 27th Annual Meeting of the European Society for Radiation Biology, September 1-4, 1996, Montpellier. Radioprotection 1997;32 (Cl):255-6
47. Levine EL, Renehan A, Gossiel R, Davidson SE, Roberts SA, Chadwick C et al. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. RadiorteT0nco/l995;37:1-9
48. Logsdon MD, McDonald TJ, Pugh WC, Besa PC, Cox JD, Cabanillas FF et al. Apoptosis, BCL-2, and BAX as predictors of tumor response in stage I and n follicular lymphoma [Abstract]. 44th Annual Meeting of the Radiation Research Society, April 14-17, 1996, Chicago, EL, USA, 1996
49. Martin L, Lartigau E, Weeger P, Lambin P, Le Ridant AM, Lusinchi A et al. Changes in the oxygenation of head and neck tumors during carbogen breathing. Radiother Oncol 1993; 27:123-30
50. Meyn R, Stephens LC, Hunter NR, Ang KA, Milas L. Reemergence of apoptotic cells between fractionated doses in irradiated murine tumors. Int 3 Radiat Oncol Biol Phys 1994;30: 619-24
51. Mirkovic N, Meyn RE, Hunter NR, Milas L. Radiation-induced apoptosis in a murine lymphoma in vivo. Radiother Oncol 1994;33:ll-6
52. Momex F, Bertrand S, N'Guyen MJ, Devriendt D, Beauchesne P, Buronfosse A et al. Bases biologiques de la résistance des astrocytomes de haut grade de malignité. Bull Cancer/Radio(fteH994;81:342-50
53. Mornex F, Coucke P, Mere P, Pavy JJ, Wilson G, Gerard JP. Le point sur l'activité du Groupe européen de radiobiologie (NCI Tpot Study T92-0045). Bull Cancer/Radiother 1995; 82:402-3
54. Nordsmark M, Hoyer M, Keller J, Nielsen OS, Jensen OM, Overgaard J. The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. Int J Radiat Oncol Biol Phys 1996;35:701 -8
55. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996; 41:31-9
56. Nylander K, Anneroth G, Gustafsson H, Roos G, Stenling R, Zackrisson B. Cell kinetics of head and neck squamous cell carcinomas. Prognostic implications. Acta Oncol 1994;33: 23-8
57. Okunieff P, Morgan D, Niemierko A, Suit HD. Radiation doseresponse of human tumors. Int J Radiat Oncol Biol Phys 1995; 32:1227-37
58. Peters LJ. Inherent radiosensitivity of tumor and normal tissue cells as a predictor of human tumor response. Radiother Oncol 1990;17:177-90
59. Peters LJ. Radiation therapy tolerance limits: for one or for all? Cancer 1996;77:2379-85
60. Raleigh JA, Dewhirst MW, Thrall DE. Measuring tumor hypoxia. Semin Radiat Oncol 1996;6:37-45
61. Reynolds TY, Rockwell S, Glazer PM. Genetic instability induced by the tumor microenvironment. Cancer Res 1996; 56:5754-7
62. Saunders MI, Dische S, Barren A, Harvey A, Gibson D, Parmar MKB. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-smallcell lung cancer: a randomised multicentre trial. Lancet 1997;350:161-5
63. Spivak JL. Cancer-related anemia: its causes and characteristics. Semin Oncol 1994;21:3-8
64. Stausbol-Gron B, Nielsen OS, Bentzen SM, Overgaard J. Selective assessment of in vitro radiosensitivity of tumour cells and fibroblasts from single tumour biopsies using immunocytochemical identification of colonies in the soft agar clonogenic assay. Radiother Oncol 1995;37:87-99
65. Stone HB, Brown JM, Phillips TL, Sutherland RM. Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held on November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland. Radiat Res 1993;136:422-34
66. 2 in cervix carcinoma. Gyneco/Onco/1997;64:230-6
67. Sutherland RM, Ausserer WA, Murphy BJ, Laderoute KR. Tumor hypoxia and heterogeneity: challenges and opportunities for the future. Semin Radiat Oncol 1996;6:59-70
68. Taghian A, Ramsay J, Allalunis-Turner J, Budach W, Gioioso D, Pardo F et al. Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1993;25: 243-9
69. Terry NH, Meistrich ML, Roubein LD, Lynch PM, Dubrow RA, Rich TA. Cellular kinetics in rectal cancer. Br J Cancer 1995; 72:435-41
70. Thames HD, Schultheiss TE, Hendry JH, Tucker SL, Dubray BM, Brock WA. Can modest excalations of dose be detected as increased tumor control? Int J Radiat Oncol Biol Phys 1991; 22:241-6
71. Trott KR. Tumour stem cells: the biological concept and its application in cancer treatment. Radiother Oncol 1994;30:1-5
72. Tsang RW, Fyles AW, Kirkbride P, Levin W, Manchul LA, Milosevic MF et al. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results. Int J Radiat Oncol Biol Phys 1995 ;32:1319-29
73. Tucker SL, Chan KS. The selection of patients for accelerated radiotherapy on the basis of tumor growth kinetics and intrinsic radiosensitivity. Radiother Oncol 1990;18:197-211
74. Tucker SL, Turesson I, Thames HD. Evidence for individual differences in the radiosensitivity of human skin. Ear J Cancer 1992;28A:1783-91
75. Tucker SL, Geara FB, Peters LJ, Brock WA. How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity? Radiother Oncol1996;38:103-13
76. Turesson I, Nyman J, Holmberg E, Odèn A. Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 1996;36:1065-75
77. West CM. Invited review: intrinsic radiosensitivity as a predictor of patient response to radiotherapy. Br J Radial 1995;68: 827-37
78. Wheeler JA, Stephens LC, Tomos C, Eifel PJ, Ang KK, Milas L et al. ASTRO research fellowship: apoptosis as a prediction of tumor response to radiation in stage IB cervical carcinoma. Int J Radial Oncol Biol Phys 1995 ;32:1487-93
79. Wilson GD, Dische S, Saunders MI. Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy. Radiother Oncol 1995;36:189-97
80. Wilson MS, West CM, Wilson GD, Roberts SA, James RD, Schofield PF. An assessment of the reliability and reproducibility of measurement of potential doubling times (Tpot) in human colorectal cancers. Br J Cancer 1993;67:754-9